🔎 Trials Near Me

Domov › Rak pljuč › Missouri

Klinične študije za Rak pljuč v Missouri

44 študij za Rak pljuč išče udeležence na lokacijah v Missouri.

Mesta v Missouri

Uradno besedilo študije (angleško)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
  • Saint Francis Medical Center, Cape Girardeau
  • Saint Luke's Hospital, Chesterfield
  • in še 18
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
  • Central Care Cancer Center - Bolivar, Bolivar
  • Cox Cancer Center Branson, Branson
  • in še 21
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Washington University, School of Medicine, St Louis
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06172478

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • Saint Francis Medical Center, Cape Girardeau
  • Kansas City Veterans Affairs Medical Center, Kansas City
  • Lake Regional Hospital, Osage Beach
  • in še 1
Vključevanje udeležencevFaza 3
Starost 70 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

  • Saint Francis Medical Center, Cape Girardeau
  • Saint Luke's Hospital, Chesterfield
  • Parkland Health Center - Farmington, Farmington
  • in še 5
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT04181060

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

  • St. Lukes Hospital of Kansas City, Kansas City
  • Washington University School of Medicine, St Louis
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06625775

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
  • University Health Truman Medical Center, Kansas City
  • Mercy Hospital South, St Louis
  • in še 1
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06498635

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  • Washington University Center for Advanced Medicine, St Louis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06765109

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

  • Washington University School of Medicine - Siteman Cancer Center, St Louis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT06881784

A Study of PHN-012 in Patients With Advanced Solid Tumors

  • PHN-012-001 Site, St Louis
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07127874

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

  • Mercy South - David M Sindelar Cancer Center ( Site 0098), St Louis
  • Mercy Research - David C. Pratt Cancer Center ( Site 0006), St Louis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06312137

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • Saint Luke's Hospital of Kansas City, Kansas City
  • Saint Luke's East Hospital, Lee's Summit
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06758401

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • Washington University School of Medicine, St Louis
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07154290

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

  • Local Institution - 0140, St Louis
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT06618287

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

  • Missouri Cancer Associates, Columbia
  • SSM Health Cancer Care - St. Clare, Fenton
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06712316

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

  • Washington University School of Medicine, St Louis
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07100080

A Study Evaluating a New Radiation Treatment Workflow (NGDS)

  • Siteman Cancer Center Washington University, St Louis
Vključevanje udeležencev
Starost 21 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07824583

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • Washington University, St Louis
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT05786924

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Oncology Hematology Associates, Springfield
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06119581

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women

  • Washington University School of Medicine, St Louis
Vključevanje udeležencevOpazovalna študija
Starost 18–50 · Ženske · Posodobljeno 2. sep. 2026 · NCT06904365

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Saint Luke's Hospital of Kansas City, Kansas City
  • Washington University School of Medicine, St Louis
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 45–75 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06995898

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

  • Washington University School of Medicine, St Louis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT06712355

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • University of Kansas Cancer Center - North, Kansas City
  • in še 6
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT06500481

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  • Saint Francis Medical Center, Cape Girardeau
  • MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia
  • Parkland Health Center - Farmington, Farmington
  • in še 11
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT05624996

Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening

  • Barnes-Jewish Hospital West County, Creve Coeur
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18 in več · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT06898333

Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital

  • Barnes-Jewish Christian Hospital, St Louis
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 20 in več · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT07146568

IDOV-Immune for Advanced Solid Tumors

  • Washington University School of Medicine, St Louis
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT06910657

Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy

  • University of Missouri - Ellis Fischel Cancer Center, Columbia
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 30. jul. 2026 · NCT06410300

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

  • Washington University School of Medicine (Siteman Cancer Center), St Louis
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 15. jul. 2026 · NCT05652686

CARE Tool Study Aim 3

  • Delbert Day Cancer Institute at Phelps Health, Rolla
  • Washington University School of Medicine, St Louis
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 8. jul. 2026 · NCT07296887

Integrated Cancer Repository for Cancer Research

  • Saint Luke's Cancer Institute, East, Kansas City
  • Saint Luke's Cancer Institute, Kansas City
  • Saint Luke's Cancer Institute, Kansas City North, Kansas City
  • in še 3
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 19–110 · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT02012699

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

  • Washington University, St Louis
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 12. jun. 2026 · NCT06051695

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

  • Research Site, St Louis
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 10. jun. 2026 · NCT06835569

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Saint Francis Medical Center, Cape Girardeau
  • Parkland Health Center - Farmington, Farmington
  • University Health Truman Medical Center, Kansas City
  • in še 9
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT05642572

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Washington University Infusion Center Pharmacy, St Louis
Vključevanje udeležencevFaza 1/2
Starost 12 in več · Vsi spoli · Posodobljeno 27. maj 2026 · NCT03093116

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Saint Francis Medical Center, Cape Girardeau
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • in še 8
Vključevanje udeležencevFaza 2
18 Minutes · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Saint Francis Medical Center, Cape Girardeau
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • in še 15
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06616584

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

  • Washington University School of Medicine, St Louis
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 22. apr. 2026 · NCT07020221

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

  • Washington University School of Medicine, St Louis
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18 in več · Vsi spoli · Posodobljeno 20. feb. 2026 · NCT04354064

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.